Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. (6NQ) Income Statement
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A. Income Statement
Last quarter (Q2 2026), Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s total revenue was $12.85M, an increase of 104.47% from the same quarter last year. In Q2, Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.'s net income was $-2.76M. See Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 42.01M | $ 71.76M | $ 58.61M | $ 50.38M | $ 41.15M | |
| $ 12.99M | $ 44.25M | $ 35.17M | $ 28.47M | $ 22.67M | |
| $ 33.57M | $ 31.82M | $ 26.52M | $ 18.09M | $ 15.47M | |
| Depreciation and Amortization | $ 13.29M | $ 8.09M | $ 6.63M | $ 6.22M | $ 6.54M |
| $ -7.28M | $ 20.84M | $ 14.89M | $ 15.40M | $ 13.09M | |
| $ -20.58M | $ 12.43M | $ 8.65M | $ 9.84M | $ 7.19M | |
| $ -3.33M | $ -2.78M | $ -2.08M | $ -1.50M | $ -1.30M | |
| $ -23.91M | $ 9.64M | $ 6.57M | $ 8.35M | $ 5.89M | |
| $ -19.93M | $ 7.55M | $ 4.76M | $ 6.08M | $ 4.25M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.27 | $ 0.11 | $ 0.07 | $ 0.09 | $ 0.07 |
| Diluted EPS | $ -0.27 | $ 0.11 | $ 0.07 | $ 0.09 | $ 0.07 |
| Weighted Average Shares Outstanding | 72.55M | 70.52M | 70.26M | 65.38M | 63.12M |
| Weighted Average Shares Outstanding (Diluted) | 72.55M | 70.52M | 70.26M | 65.38M | 63.12M |
Currency in PLN
